Northern Trust Corp Pulse Biosciences, Inc. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 204,505 shares of PLSE stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,505
Previous 210,458 2.83%
Holding current value
$3.15 Million
Previous $3.89 Million 15.4%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$15.61 - $24.56 $92,926 - $146,205
-5,953 Reduced 2.83%
204,505 $3.29 Million
Q4 2024

Feb 14, 2025
BUY
$14.56 - $21.08 $3,814 - $5,522
262 Added 0.12%
210,458 $3.89 Million
Q3 2024

Nov 13, 2024
BUY
$10.83 - $21.83 $314,405 - $633,746
29,031 Added 16.02%
210,196 $3.69 Million
Q2 2024

Aug 14, 2024
SELL
$6.69 - $14.54 $39,999 - $86,934
-5,979 Reduced 3.19%
181,165 $2.03 Million
Q1 2024

May 14, 2024
BUY
$7.8 - $11.02 $27,136 - $38,338
3,479 Added 1.89%
187,144 $1.63 Million
Q4 2023

Feb 13, 2024
BUY
$3.85 - $12.84 $18,776 - $62,620
4,877 Added 2.73%
183,665 $2.25 Million
Q3 2023

Nov 13, 2023
BUY
$4.03 - $8.73 $6,133 - $13,287
1,522 Added 0.86%
178,788 $720,000
Q2 2023

Aug 11, 2023
BUY
$3.67 - $8.64 $376,604 - $886,610
102,617 Added 137.47%
177,266 $1.27 Million
Q1 2023

May 15, 2023
BUY
$2.48 - $3.88 $2,155 - $3,371
869 Added 1.18%
74,649 $250,000
Q4 2022

Feb 13, 2023
SELL
$1.73 - $2.89 $674 - $1,127
-390 Reduced 0.53%
73,780 $204,000
Q3 2022

Nov 14, 2022
BUY
$1.23 - $2.3 $2,603 - $4,869
2,117 Added 2.94%
74,170 $171,000
Q2 2022

Aug 12, 2022
SELL
$1.48 - $4.28 $144,718 - $418,511
-97,783 Reduced 57.57%
72,053 $110,000
Q1 2022

May 13, 2022
SELL
$4.21 - $14.79 $28,392 - $99,743
-6,744 Reduced 3.82%
169,836 $825,000
Q4 2021

Feb 08, 2022
SELL
$14.78 - $24.4 $31,111 - $51,362
-2,105 Reduced 1.18%
176,580 $2.62 Million
Q3 2021

Nov 15, 2021
SELL
$17.25 - $26.63 $181,901 - $280,813
-10,545 Reduced 5.57%
178,685 $3.86 Million
Q2 2021

Aug 13, 2021
SELL
$16.31 - $23.64 $124,673 - $180,704
-7,644 Reduced 3.88%
189,230 $3.1 Million
Q1 2021

May 12, 2021
SELL
$22.43 - $44.27 $939,435 - $1.85 Million
-41,883 Reduced 17.54%
196,874 $4.66 Million
Q4 2020

Feb 11, 2021
SELL
$11.66 - $24.5 $157,899 - $331,779
-13,542 Reduced 5.37%
238,757 $5.7 Million
Q3 2020

Nov 16, 2020
SELL
$9.27 - $13.14 $58,595 - $83,057
-6,321 Reduced 2.44%
252,299 $2.97 Million
Q2 2020

Aug 14, 2020
BUY
$6.23 - $13.09 $649,265 - $1.36 Million
104,216 Added 67.5%
258,620 $2.71 Million
Q1 2020

May 14, 2020
BUY
$5.23 - $15.2 $37,263 - $108,300
7,125 Added 4.84%
154,404 $1.11 Million
Q4 2019

Feb 14, 2020
BUY
$12.58 - $15.97 $77,882 - $98,870
6,191 Added 4.39%
147,279 $1.98 Million
Q3 2019

Nov 13, 2019
BUY
$10.73 - $17.33 $180,392 - $291,351
16,812 Added 13.53%
141,088 $2.18 Million
Q2 2019

Aug 13, 2019
BUY
$11.11 - $17.34 $27,263 - $42,552
2,454 Added 2.01%
124,276 $1.64 Million
Q1 2019

May 13, 2019
BUY
$11.69 - $19.44 $9,246 - $15,377
791 Added 0.65%
121,822 $2.14 Million
Q4 2018

Feb 12, 2019
BUY
$9.08 - $14.34 $101,804 - $160,780
11,212 Added 10.21%
121,031 $1.39 Million
Q3 2018

Nov 14, 2018
BUY
$12.83 - $16.45 $31,985 - $41,009
2,493 Added 2.32%
109,819 $1.56 Million
Q2 2018

Aug 14, 2018
BUY
$14.04 - $20.28 $199,803 - $288,604
14,231 Added 15.29%
107,326 $1.63 Million
Q1 2018

May 09, 2018
SELL
$12.67 - $24.69 $42,583 - $82,983
-3,361 Reduced 3.48%
93,095 $1.26 Million
Q4 2017

Feb 14, 2018
SELL
$18.81 - $30.33 $25,073 - $40,429
-1,333 Reduced 1.36%
96,456 $2.28 Million
Q3 2017

Nov 13, 2017
BUY
$10.26 - $24.97 $1 Million - $2.44 Million
97,789
97,789 $1.82 Million

Others Institutions Holding PLSE

# of Institutions
88
Shares Held
5.55M
Call Options Held
76.1K
Put Options Held
60.8K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $572M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email